The core tension is between the promising quantum/AME commercial traction (INSU300 launch, customer production conversion, leading quantum company evaluation) and the severe financial overhang (going concern, massive dilution, $86M accumulated losses, no medical revenue). Watch for Q4 2026 commercial agreement announcements and the 2027 financial outlook, which the CEO claims will describe a 'substantially larger business.' The August 2026 offering at $0.90/share (below the $1.50 June offering price) signals continued dilution pressure. The going concern qualification means any operational miss could trigger a liquidity crisis.
Price Chart
Executive Summary
QTREX Quantum reported H1 2026 revenue of $1.55M (up 438% YoY from $289K), entirely from the newly acquired AME and Quantum segment in its first 86 days post-acquisition. The consolidated net loss was $6.4M ($0.14/share), essentially flat YoY. The company highlighted the launch of INSU300, progress with a leading quantum computing company, and expects to announce additional commercial agreements in Q4 2026. However, the filing also discloses a going concern qualification, accumulated losses of $86M, and significant shareholder dilution (shares outstanding increased from 35.9M to 55.4M in six months).
Key Facts
- H1 2026 revenue of $1.55M, up 438% from $289K in H1 2025, entirely from the acquired AME and Quantum segment.
- Consolidated gross profit of $944K, representing a 61% gross margin.
- Net loss of $6.4M ($0.14 per share), compared to $6.4M ($0.24 per share) in H1 2025.
- Cash and cash equivalents of $10.7M as of June 30, 2026, up from $3.2M at Dec 31, 2025.
- Subsequent to period end, raised ~$10M gross (Aug 20, 2026) via a registered direct offering of 11.1M shares at $0.90/share.
- Accumulated losses of $86M as of June 30, 2026.
- Going concern qualification: 'substantial doubt about our ability to continue as a going concern' due to dependency on external funding.
- Shares outstanding increased from 35,949,247 (Dec 31, 2025) to 55,406,688 (June 30, 2026), a 54% dilution in six months.
- Launched INSU300 RF dielectric and dedicated AME system on Sept 23, 2026; initial deployments at two government/defense organizations.
- Joint technical evaluation with one of the world's five leading quantum computing companies is progressing; additional requirements agreed and several testing stages completed.
- One of the largest U.S. interconnect manufacturers moved its AME system from development to production after achieving 97% yield.
- Received a commercial order for customized shielded RF monolithic components from a leading government-owned international company.
- Company expects to announce additional commercial agreements in Q4 2026 and provide a 2027 financial outlook.
- Medical Technology segment recorded no revenue and an operating loss of $5.5M in H1 2026.
- Pro forma revenue for the six months ended June 30, 2026, assuming the acquisition occurred Jan 1, 2025, would have been $3.35M with a pro forma net loss of $10.05M.
Financial Impact
Revenue increased by $1.26M YoY (438%) driven by the AME acquisition, but net loss remained essentially flat at $6.4M. The company raised ~$23.7M in gross proceeds from equity offerings in H1 2026 and a subsequent August 2026 offering, offsetting ongoing cash burn of $3.9M in operating cash flow.
Risk Factors
- Going concern qualification: substantial doubt about ability to continue as a going concern due to dependency on external funding.
- Massive shareholder dilution: shares outstanding increased 54% in six months (35.9M to 55.4M), with a further 11.1M shares issued in August 2026.
- Medical Technology segment is a cash drain with no revenue and $5.5M operating loss; monetization efforts may not succeed.
- Revenue concentration: H1 2026 revenue of $1.55M is still very small; the company is pre-revenue in its core quantum connectivity strategy.
- Execution risk: the company must convert technical evaluations and validation deployments into recurring commercial revenue.
- Geopolitical risk: operations in Israel with ongoing regional instability and military conflicts.
- Nasdaq compliance risk: history of bid price deficiency; risk of future delisting if share price falls below $1.00.
- Contingent consideration liability of up to $10.5M payable to Nano Dimension based on net cash collected from acquired assets over 12 months.
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001185185-26-004282 |
| Document: qtrexex99-3.htm | 0001185185-26-004282 |
| Document: qtrexex99-1.htm | 0001185185-26-004282 |
| Document: qtrex6k092226.htm | 0001185185-26-004282 |
| Document: 0001185185-26-004282-index-headers.html | 0001185185-26-004282 |
| Document: 0001185185-26-004282-index.html | 0001185185-26-004282 |
| Document: 0001185185-26-004282.txt | 0001185185-26-004282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 6-K | $1.40 $1.29 | ▼ −7.86% | ▼ −7.71% | $1.29 (−7.86%) |
Oct 19, 2026 7d ago | Press Release | $1.40 $1.29 | ▼ −8.21% | ▼ −8.07% | $1.29 (−7.86%) |
Oct 1, 2026 25d ago | 6-K | $0.7850 $1.69 | ▲ +115.29% | ▲ +113.99% | $1.29 (+64.33%) |
Oct 1, 2026 25d ago | Press Release | $0.7850 $1.69 | ▲ +115.29% | ▲ +113.99% | $1.29 (+64.33%) |
Sep 24, 2026 4w ago | 6-K | $0.7760 $1.10 | ▲ +41.75% | ▲ +41.97% | $1.29 (+66.24%) |
Sep 24, 2026 4w ago | Press Release | $0.7603 $0.7846 | ▲ +3.20% | ▲ +3.61% | $1.29 (+69.67%) |
Sep 2, 2026 7w ago | 6-K | $0.8160 $0.8184 | ▲ +0.29% | ▲ +1.25% | $1.29 (+58.09%) |
Aug 21, 2026 9w ago | 424B5 | $0.9155 $0.8340 | ▲ +8.90% | ▲ +9.38% | $1.29 (−40.91%) |
Aug 19, 2026 9w ago | 6-K | $1.12 $0.8185 | ▼ −26.92% | ▼ −26.53% | $1.29 (+15.18%) |
Aug 3, 2026 12w ago | 6-K | $1.01 $1.04 | ▲ +2.97% | ▲ +0.94% | $1.29 (+27.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers